J&J says booster shot provides 100 percent protection against severe COVID-19


New data indicates that a booster shot of Johnson & Johnson's vaccine provides 100 percent protection against severe COVID-19, the company announced Tuesday.
Johnson & Johnson said that in a phase 3 trial, a booster shot of its vaccine given after two months provided 94 percent protection against symptomatic COVID-19 in the United States, and it also provided 100 percent protection against severe COVID-19 "at least 14 days post-final vaccination." Antibody levels "rose to four to six times higher than observed after the single shot," the company said. The booster shot provided 75 percent protection globally.
"We now have generated evidence that a booster shot further increases protection against COVID-19 and is expected to extend the duration of protection significantly," Johnson & Johnson Chief Scientific Officer Paul Stoffels said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Johnson & Johnson also said that when a booster was given six months after the first shot, there was a 12-fold increase in antibodies. The data suggests that "if you wait longer and have boost at six months or later then you likely will have better boost," Beth Israel Deaconess' Center for Virology and Vaccine Research head Dr. Dan Barouch explained to CNN.
Johnson & Johnson said it has provided this data to the Food and Drug Administration. An FDA advisory panel recently met to consider whether to authorize a booster shot of the Pfizer COVID-19 to those over 16 in the United States, but they ultimately decided not to do so, instead recommending it for those over 65 or at high risk for severe COVID-19. The Biden administration had initially planned to administer COVID-19 booster shots to all adults beginning this week. Administration health officials said last month that "booster shots will likely be needed for people who received the Johnson & Johnson" vaccine, and they said they would "keep the public informed with a timely plan" for administering these boosters once there was more data available.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Art review: Diane Arbus: Constellation
Feature Park Avenue Armory, New York City, through Aug. 17
-
July fiction: Summers to remember
Feature Featuring the latest summer-themed novels from Darrow Farr, Lucas Schaefer, and more
-
Why are flash floods in Texas so deadly?
Today's Big Question Over 100 people, including 27 girls at a summer camp, died in recent flooding
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'